Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / OVID - Ovid Therapeutics: High Risk/High Reward


OVID - Ovid Therapeutics: High Risk/High Reward

"Miracles are like pimples, because once you start looking for them, you find more than you ever dreamed you'd see." - Lemony Snicket, The Lump of Coal

Today we take a look a developmental biotech concern that is deep in "Busted IPO" territory. However, if things fall right for the company, substantial capital appreciation could lie ahead. A full analysis is presented in the paragraphs below.

Company Overview

Ovid Therapeutics, Inc. (OVID) is a New York City-based biopharmaceutical concern focused on the development of therapies for the treatment of rare neurological disorders.

Read more ...

Stock Information

Company Name: Ovid Therapeutics Inc.
Stock Symbol: OVID
Market: NASDAQ
Website: ovidrx.com

Menu

OVID OVID Quote OVID Short OVID News OVID Articles OVID Message Board
Get OVID Alerts

News, Short Squeeze, Breakout and More Instantly...